Tuesday, May 26, 2026
spot_img

Don't Miss

Allergan Aesthetics launches HArmonyCa with Lidocaine

Allergan Aesthetics announces Health Canada Authorization for HArmonyCa® with Lidocaine, a next generation collagen stimulation injectable, that combines hyaluronic acid (HA) and calcium hydroxyapatite...

Clinical Trials

Allergan Aesthetics receives positive CHMP opinion for Boey across Europe

Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics, announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human...

Lumenis Aesthetics showcases new clinical data across skin and hair loss indications

Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced new clinical data from its portfolio of industry-leading...

EVENTS

Funding

Conexeu Sciences commences trading on Nasdaq under ticker symbol “CNXU”

Conexeu Sciences Inc., a biotechnology company advancing tissue regeneration, announced it has officially commenced trading on the Nasdaq today under the ticker symbol “CNXU.”...
- Advertisement -

Featured

Latest Reviews

Allergan Aesthetics launches HArmonyCa with Lidocaine

Allergan Aesthetics announces Health Canada Authorization for HArmonyCa® with Lidocaine, a next generation collagen stimulation injectable, that combines hyaluronic acid (HA) and calcium hydroxyapatite...

Mergers & Acquisitions

$200M merger of Dominion and BellaMia creates new laser robotic leader

Dominion Aesthetic Technologies, Inc. and BellaMia Technologies, Inc. announced they have completed a strategic merger. Dominion is the creator of EON®, the leader in...

Koru Pharma announces strategic partnership with LYFE Capital

Koru Pharma is pleased to announce a strategic partnership with LYFE Capital, a global healthcare investment firm. As part of this agreement, LYFE Capital...

Senté announces strategic partnership and equity financing

Senté, a leader in medical-grade skincare innovation, announced the successful closing of a strategic partnership and equity financing. This milestone positions the company to...

Phiusion Labs announces a strategic distribution partnership with Proteos Biotech S.L.

Phiusion Labs Inc. announced a strategic partnership with Proteos Biotech S.L.. This partnership will facilitate the distribution of the PBSerum® product portfolio across the...

Hugel to enter ECM-based injectable market with aesthetic portfolio expansion

Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has accelerated its growth strategy by adding an extracellular matrix (ECM)-based...
- Advertisement -
Advertismentspot_imgspot_img
Advertismentspot_imgspot_img